Cargando…

Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine Resistance

Circulating tumor cells (CTCs) hold great promise with regard to prognosis, treatment optimization, and monitoring of breast cancer patients. Single CTC transcriptome profiling might help reveal valuable information concerning intra-patient heterogeneity relevant to therapeutic interventions. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinhardt, Florian, Franken, André, Meier-Stiegen, Franziska, Driemel, Christiane, Stoecklein, Nikolas H., Fischer, Johannes C., Niederacher, Dieter, Ruckhaeberle, Eugen, Fehm, Tanja, Neubauer, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679140/
https://www.ncbi.nlm.nih.gov/pubmed/31261643
http://dx.doi.org/10.3390/cancers11070903
_version_ 1783441269408661504
author Reinhardt, Florian
Franken, André
Meier-Stiegen, Franziska
Driemel, Christiane
Stoecklein, Nikolas H.
Fischer, Johannes C.
Niederacher, Dieter
Ruckhaeberle, Eugen
Fehm, Tanja
Neubauer, Hans
author_facet Reinhardt, Florian
Franken, André
Meier-Stiegen, Franziska
Driemel, Christiane
Stoecklein, Nikolas H.
Fischer, Johannes C.
Niederacher, Dieter
Ruckhaeberle, Eugen
Fehm, Tanja
Neubauer, Hans
author_sort Reinhardt, Florian
collection PubMed
description Circulating tumor cells (CTCs) hold great promise with regard to prognosis, treatment optimization, and monitoring of breast cancer patients. Single CTC transcriptome profiling might help reveal valuable information concerning intra-patient heterogeneity relevant to therapeutic interventions. In this study, we combined Diagnostic Leukapheresis (DLA), which is a microfluidic enrichment using the Parsortix(TM) system, micromanipulation with CellCelector(TM) and subsequent single cell multi-marker transcriptome profiling. First, a PCR panel consisting of 30 different endocrine resistance and phenotypic marker genes was validated for single cell profiling by using different breast cancer cell lines. Second, this panel was applied to characterize uncultured and cultured CTCs, which were enriched from a cryopreserved DLA product obtained from a patient suffering from metastatic breast cancer resistant to endocrine therapy. Gene expression profiles of both CTC populations uncovered inter CTC heterogeneity for transcripts, which are associated with response or resistance to endocrine therapy (e.g., ESR1, HER2, FGFR1). Hierarchical clustering revealed CTC subpopulations with different expressions of transcripts regarding the CTCs’ differential phenotypes (EpCAM, CD44, CD24, MYC, MUC1) and of transcripts involved in endocrine signaling pathways (FOXO, PTEN). Moreover, ER-positive CTCs exhibited significant higher expression of Cyclin D1, which might be relevant for CDK4/6 inhibitor therapies. Overall, gene expression profiles of uncultured and cultured CTCs resulted in a partly combined grouping. Our findings demonstrate that multi-marker RNA profiling of enriched single uncultured CTCs and cultured CTCs form cryopreserved DLA samples may provide important insights into intra-patient heterogeneity relevant for targeted therapies and therapy resistance.
format Online
Article
Text
id pubmed-6679140
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-66791402019-08-19 Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine Resistance Reinhardt, Florian Franken, André Meier-Stiegen, Franziska Driemel, Christiane Stoecklein, Nikolas H. Fischer, Johannes C. Niederacher, Dieter Ruckhaeberle, Eugen Fehm, Tanja Neubauer, Hans Cancers (Basel) Article Circulating tumor cells (CTCs) hold great promise with regard to prognosis, treatment optimization, and monitoring of breast cancer patients. Single CTC transcriptome profiling might help reveal valuable information concerning intra-patient heterogeneity relevant to therapeutic interventions. In this study, we combined Diagnostic Leukapheresis (DLA), which is a microfluidic enrichment using the Parsortix(TM) system, micromanipulation with CellCelector(TM) and subsequent single cell multi-marker transcriptome profiling. First, a PCR panel consisting of 30 different endocrine resistance and phenotypic marker genes was validated for single cell profiling by using different breast cancer cell lines. Second, this panel was applied to characterize uncultured and cultured CTCs, which were enriched from a cryopreserved DLA product obtained from a patient suffering from metastatic breast cancer resistant to endocrine therapy. Gene expression profiles of both CTC populations uncovered inter CTC heterogeneity for transcripts, which are associated with response or resistance to endocrine therapy (e.g., ESR1, HER2, FGFR1). Hierarchical clustering revealed CTC subpopulations with different expressions of transcripts regarding the CTCs’ differential phenotypes (EpCAM, CD44, CD24, MYC, MUC1) and of transcripts involved in endocrine signaling pathways (FOXO, PTEN). Moreover, ER-positive CTCs exhibited significant higher expression of Cyclin D1, which might be relevant for CDK4/6 inhibitor therapies. Overall, gene expression profiles of uncultured and cultured CTCs resulted in a partly combined grouping. Our findings demonstrate that multi-marker RNA profiling of enriched single uncultured CTCs and cultured CTCs form cryopreserved DLA samples may provide important insights into intra-patient heterogeneity relevant for targeted therapies and therapy resistance. MDPI 2019-06-28 /pmc/articles/PMC6679140/ /pubmed/31261643 http://dx.doi.org/10.3390/cancers11070903 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Reinhardt, Florian
Franken, André
Meier-Stiegen, Franziska
Driemel, Christiane
Stoecklein, Nikolas H.
Fischer, Johannes C.
Niederacher, Dieter
Ruckhaeberle, Eugen
Fehm, Tanja
Neubauer, Hans
Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine Resistance
title Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine Resistance
title_full Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine Resistance
title_fullStr Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine Resistance
title_full_unstemmed Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine Resistance
title_short Diagnostic Leukapheresis Enables Reliable Transcriptomic Profiling of Single Circulating Tumor Cells to Characterize Inter-Cellular Heterogeneity in Terms of Endocrine Resistance
title_sort diagnostic leukapheresis enables reliable transcriptomic profiling of single circulating tumor cells to characterize inter-cellular heterogeneity in terms of endocrine resistance
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679140/
https://www.ncbi.nlm.nih.gov/pubmed/31261643
http://dx.doi.org/10.3390/cancers11070903
work_keys_str_mv AT reinhardtflorian diagnosticleukapheresisenablesreliabletranscriptomicprofilingofsinglecirculatingtumorcellstocharacterizeintercellularheterogeneityintermsofendocrineresistance
AT frankenandre diagnosticleukapheresisenablesreliabletranscriptomicprofilingofsinglecirculatingtumorcellstocharacterizeintercellularheterogeneityintermsofendocrineresistance
AT meierstiegenfranziska diagnosticleukapheresisenablesreliabletranscriptomicprofilingofsinglecirculatingtumorcellstocharacterizeintercellularheterogeneityintermsofendocrineresistance
AT driemelchristiane diagnosticleukapheresisenablesreliabletranscriptomicprofilingofsinglecirculatingtumorcellstocharacterizeintercellularheterogeneityintermsofendocrineresistance
AT stoeckleinnikolash diagnosticleukapheresisenablesreliabletranscriptomicprofilingofsinglecirculatingtumorcellstocharacterizeintercellularheterogeneityintermsofendocrineresistance
AT fischerjohannesc diagnosticleukapheresisenablesreliabletranscriptomicprofilingofsinglecirculatingtumorcellstocharacterizeintercellularheterogeneityintermsofendocrineresistance
AT niederacherdieter diagnosticleukapheresisenablesreliabletranscriptomicprofilingofsinglecirculatingtumorcellstocharacterizeintercellularheterogeneityintermsofendocrineresistance
AT ruckhaeberleeugen diagnosticleukapheresisenablesreliabletranscriptomicprofilingofsinglecirculatingtumorcellstocharacterizeintercellularheterogeneityintermsofendocrineresistance
AT fehmtanja diagnosticleukapheresisenablesreliabletranscriptomicprofilingofsinglecirculatingtumorcellstocharacterizeintercellularheterogeneityintermsofendocrineresistance
AT neubauerhans diagnosticleukapheresisenablesreliabletranscriptomicprofilingofsinglecirculatingtumorcellstocharacterizeintercellularheterogeneityintermsofendocrineresistance